Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease

Jelena Kotur-Stevuljević1, Amira Peco-Antić, Slavica Spasić

  • 1Department for Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, P. Box 146, 11000 Belgrade, Serbia. jkotur@pharmacy.bg.ac.rs

Insights

Children with chronic kidney disease (CKD) experience early atherosclerosis due to dyslipidemia and oxidative stress. Monitoring these factors and vessel wall changes is crucial for effective treatment strategies.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Biochemistry

Background:

  • Investigated the roles of dyslipidemia and oxidative stress in early atherosclerosis among pediatric chronic kidney disease (CKD) patients.
  • Utilized common carotid artery intima-media thickness (cIMT) as a biomarker for subclinical atherosclerosis.

Purpose of the Study:

  • To evaluate the association between dyslipidemia, oxidative stress, and early atherosclerotic changes in children with CKD.
  • To assess lipid and oxidative stress parameters in pediatric CKD patients undergoing different treatment modalities.

Main Methods:

  • Enrolled 52 pediatric CKD patients (chronic renal failure, renal transplant, chronic hemodialysis) and 36 healthy controls.
  • Assessed lipid profiles, oxidative stress markers (malondialdehyde), antioxidant status (superoxide dismutase), and paraoxonase 1 (PON1).
  • Measured cIMT using ultrasound, adjusting for age and sex to obtain standard deviation scores (SDS).

Main Results:

  • Pediatric CKD patients exhibited dyslipidemia, most significantly in chronic hemodialysis patients, with elevated free cholesterol and triglycerides.
  • Markedly increased oxidative stress (higher malondialdehyde) and compromised antioxidant defense (lower superoxide dismutase) were observed in CKD groups compared to controls.
  • Multiple regression analysis indicated that disease duration, blood pressure, urea, lipid, and oxidative status parameters explained over 90% of the variability in cIMT-SDS.

Conclusions:

  • Dyslipidemia and oxidative stress contribute significantly to the pathogenesis of early atherosclerosis in children with CKD.
  • Monitoring vascular changes, oxidative stress, and high-density lipoprotein (HDL) functionality is essential for developing improved therapeutic strategies to mitigate atherosclerotic progression.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...